S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
US joins in other nations in swearing off coal power to clean the climate
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
BMW recalls SUVs after Takata air bag inflator blows apart, hurling shrapnel and injuring driver
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
US joins in other nations in swearing off coal power to clean the climate
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
BMW recalls SUVs after Takata air bag inflator blows apart, hurling shrapnel and injuring driver
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
US joins in other nations in swearing off coal power to clean the climate
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
BMW recalls SUVs after Takata air bag inflator blows apart, hurling shrapnel and injuring driver
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
US joins in other nations in swearing off coal power to clean the climate
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
BMW recalls SUVs after Takata air bag inflator blows apart, hurling shrapnel and injuring driver

Exicure Stock Price, News & Analysis (NASDAQ:XCUR)

$0.47
+0.01 (+2.17%)
(As of 12/1/2023 ET)
Compare
Today's Range
$0.46
$0.48
50-Day Range
$0.46
$0.78
52-Week Range
$0.44
$1.78
Volume
5,699 shs
Average Volume
15,011 shs
Market Capitalization
$4.07 million
P/E Ratio
0.28
Dividend Yield
N/A
Price Target
N/A

Exicure MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
3.00% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.67
Upright™ Environmental Score
News Sentiment
0.93mentions of Exicure in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.14 out of 5 stars


XCUR stock logo

About Exicure Stock (NASDAQ:XCUR)

Exicure, Inc., an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.

XCUR Stock Price History

XCUR Stock News Headlines

Exicure Inc XCUR
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Exicure (XCUR) Earnings Dates & Reports
Exicure Lays Off Two-Third Employees, Ceases R&D Activities
See More Headlines
Receive XCUR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exicure and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/19/2021
Today
12/03/2023
Next Earnings (Estimated)
12/04/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:XCUR
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Net Income
$-2,580,000.00
Pretax Margin
13.76%

Debt

Sales & Book Value

Annual Sales
$28.83 million
Book Value
$3.00 per share

Miscellaneous

Free Float
8,311,000
Market Cap
$4.07 million
Optionable
Not Optionable
Beta
1.18
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Paul Kang (Age 61)
    CEO & Director
  • Ms. Jiyoung Hwang (Age 46)
    CFO & Director
  • Mr. Joshua Miller (Age 47)
    Chief Accounting Officer
  • Mr. Bart Anderson
    Senior Director of R&D














XCUR Stock Analysis - Frequently Asked Questions

How have XCUR shares performed in 2023?

Exicure's stock was trading at $1.15 on January 1st, 2023. Since then, XCUR shares have decreased by 59.1% and is now trading at $0.4701.
View the best growth stocks for 2023 here
.

When is Exicure's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, December 4th 2023.
View our XCUR earnings forecast
.

How were Exicure's earnings last quarter?

Exicure, Inc. (NASDAQ:XCUR) posted its quarterly earnings results on Friday, November, 19th. The company reported ($8.10) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($2.70) by $5.40. The business had revenue of ($3.68) million for the quarter, compared to analyst estimates of $0.80 million.

When did Exicure's stock split?

Exicure's stock reverse split on the morning of Thursday, June 30th 2022. The 1-30 reverse split was announced on Thursday, June 30th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 30th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

How do I buy shares of Exicure?

Shares of XCUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:XCUR) was last updated on 12/3/2023 by MarketBeat.com Staff

My Account -